A thorough evaluation involving a neurologist or a neuromuscular specialist, alongside a stem cell therapy expert, is paramount. The progressive nature of Muscular Dystrophy necessitates the pursuit ...
Duchenne Muscular Dystrophy, with its progressive and debilitating nature, necessitates the exploration of innovative therapeutic avenues. Stem cell therapy, with its potential for muscle restoration ...
At its July meeting, the CIRM governing Board was honored to hear from Caleb Sizemore, a delightful and courageous young man who was born with Duchenne muscular dystrophy ... CIRM-funded trial testing ...
Current treatments can slow muscle damage ... PTPN1/2 inhibition promotes muscle stem cell differentiation in Duchenne muscular dystrophy. Life Sci Alliance. 2025;8(1):e202402831. doi: ...
Ips Heart Inc. has been awarded orphan drug designation by the FDA for its GIVI-MPC stem cell therapy for Becker muscular dystrophy. GIVI-MPC has the unique ability to create new muscle with full ...
IPS HEART has been awarded Orphan Drug Designation (ODD) by the FDA for GIVI-MPCs based on its unique ability to create new muscle with full length dystrophin in Becker Muscular Dystrophy(BMD). IPS ...
The dysferlin protein is primarily responsible for repairing cell membranes ... successfully removed muscle stem cells from two patients with limb-girdle muscular dystrophy, corrected the genetic ...
The positive results from the second part of the EMBARK trial contrast with findings from one-year post treatment, which did ...
An Irish woman has launched a fundraiser to help raise money for medical treatment for her seven-year-old son. Una Ennis' son ...
IPS HEART has now shown GIVI-MPCs create new human muscle with full length human dystrophin in dystrophic pigs, young and extremely aged Duchenne Muscular Dystrophy (DMD) mice and in a sarcopenia ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback